Advancing the delivery of glucagon

Gvoke HypoPen® is the first autoinjector for severe hypoglycemia1,2


Gvoke HypoPen3
Gvoke HypoPen® (glucagon injection)
  • Premixed and ready-to-go, so it is ready-to-use1,2
  • Anyone can use in 2 simple steps2,3
  • No visible needle
  • No refrigeration required1
  • Available in 2 premeasured doses (0.5 mg for children and 1.0 mg for adults)
References: 1. Gvoke [prescribing information], Chicago, IL; Xeris Pharmaceuticals, Inc. 2. Gvoke HypoPen [instructions for use], Chicago, IL: Xeris Pharmaceuticals, Inc. 3. Valentine V, Newswanger B, Prestrelski S, Andre AD, Garibaldi M. Human factors usability and validation studies of a glucagon autoinjector in a simulated severe hypoglycemia rescue situation. Diabetes Technol Ther. 2019;21(9):522-530.